Up to 5 million RMB
- Medical device projects
- 1st phase - up to 2 million RMB
- 2nd phase - up to 1 million RMB
- Biomedical projects
- 1st phase - up to 3 million RMB
- 2nd phase - up to 2 million RMB
en-big最新首页
ABOUT US
Guangzhou Sino-Israel Bio-Industry Incubaion Center
Guangzhou Sino-Israel Bio-Industry Incubation Center(“BIG”) was established in August 2018 with its mission to promote the development cooperation of the biological industry, fully benchmark from the Israeli government's model of supporting innovation and entrepreneurship, issue new policies in light of local conditions to identify and invest in promising medical device and drugs from all over the world and bring them to Guangzhou. Since its establishment, BIG has settled 17 projects from Israel, Britain, mainland China and other places, 5 of them have successfully exited the incubator.
History
2012
The cooperation between Guangzhou International Bio Island and Dr. Shuki Gleitman’s team was forged
2013
Guangzhou was approved by the National Development and Reform Commission as one of the four key regions in China for high-tech industrial cooperation between China and Israel
2015
Guangzhou Sino-Israel Bio Industry Investment Fund (GIBF) was launched
2017
Incubator management company – Guangzhou Yisheng Investment Company was established
A special fund policy to support incubation projects from BIG was released by Guangzhou Development District (Guangzhou Huangpu District)
2018
The Guangzhou Sino-Israel Bio Industry Incubation Center was launched in Guangzhou International Bio Island, embracing its first two projects for incubation
2020
First project graduated and exit the incubator
2022
Guangzhou Sino-Israel cooperation has been included in the 14th Five Year Plan of Guangzhou
2023
Version 2.0 of the special fund policy was released
TEAM
DR. YEHOSHUA (SHUKI) GLEITMAN
Prominent world leader in the fields of national R&D policies and planning, innovation, technology-based investments, and establishment of national and regional innovation agencies and incentive mechanisms
- The legendary Chief Scientist of the State of Israel and Director General of the Israeli Ministry of Industry and Trade with many rights in the creation of the Israeli high-tech phenomenon
- Senior consultant to the World Bank on national R&D policies
- Consultant to many countries, including: Singapore, Korea, South Africa, Serbia, Poland
- Chair of the U.S.-Israel Industrial R&D Foundation
- Joint chair of the U.S.-Israel Science and Technology Commission
- Senior management positions (Chairman/CEO) of many companies (public & private) and funds/investment companies in the private sector
- Consul General of Singapore to Israel
- Honorary Citizen of Guangzhou City
- Friendship Award of Guangdong Province
- Holds bachelors of science, master of science and Ph.D. degrees in physical chemistry from the Hebrew University of Jerusalem
Read more
CARL GENG
Significant experience in government relations and strong knowledge of international high-tech transfer and governmental development plans in China
- Co-leader of Shanghai International Cleantech Accelerator
- Chief Researcher of South North Institute of Sustainable Development (SNISD)
- Chief Researcher of South North Institute of Sustainable Development (SNISD)
- International Department of Ministry of Foreign Affairs of PRC, including 4 years member of the Chinese mission to UN in New York. Chinese representative to various international economic organizations such as IMF, World Bank and WTO. Initiated and pushed forward Chinese participation in PECC (Pacific Economic Cooperation Council) and Asian Development Bank
- Consulting services to Chinese government and enterprises in the field of international relationship
- Assistant Secretary General and Deputy Secretary General for the International Scientific Exchange Foundation of China (ISEFC). Initiated some innovative international projects for high tech cooperation and commercialization, mainly in new energy, cleantech, biotech and new agriculture
Read more
AVNER LUSHI
One of the leading life sciences investors in Israel with over 20 years' experience
- Partner and Managing Director of Israel Healthcare Ventures (IHCV), a prominent Israeli life sciences venture capital fund
- Co-Founder & CEO of Life Sciences Transaction Support Ltd. (LTS), a PwC subsidiary dealing with life sciences investment banking
- Independent board member in 12 industrial companies (9 of them public, traded on NASAQ or Tel-Aviv Stock Exchange)
- Prior to turning to the private sector, served in senior positions at the Israeli Prime Minister Chamber and the Israeli Supreme Court
Read more
PROF. SHLOMO NOY
World level expert on healthcare management, tech transfer, building ecosystems and focusing hospitals on research and clinical trials
- Sheba Medical Center (largest governmental hospital in Israel and one of the top 10 hospitals of the world according to Newsweek)
- Vice President and Acting Director for Research and Development
- Founder and Chair of Sheba Tech Transfer Company
- Director of the Chaim Sheba Medical Center Rehabilitation Hospital
- Responsible for clinical trials (2000 annually)
- Chairman of the Helsinki Committee (IRB - Institutional Review Board)
- Chairman of the Patents Committee
- Professor of Medicine at the Sackler School of Medicine, Tel Aviv University
- Published more than 80 articles and book chapters
- President, Ono Academic College (the largest college in Israel)
- Ph.D. Health Policy, Tel Aviv University; M.D., The Hebrew University of Jerusalem Hadassah Medical School; MBA, INSEAD, Fontainebleau, France.
Read more
RAY ZHANG
Over 15 years’ experience in international cooperation and investment promotion
- Deputy General Manager of Guangzhou International Bio-Island Group
- Participated in the Guangzhou Development District’s international cooperations, including UK, Israel, etc.
- Working with different local governments and participated in multiple development and investment projects, including Guangdong Zhaoqing, Shenzhen-Shantou Cooperation District, Yunnan Qujing, Jiangsu Liyang, Guangxi Nanning, etc.
- Core member of major projects of Guangzhou Development District. Participated in implementation of China-Singapore cooperation project and LG project.
Read more
PARTNERS
我们如何做
HOW WE WORK
PORTFOLIOS
Sunscell Technology (China)
Automatic cell production system
Technology
FangAI (China)
AI Fungi diagnosis system
Technology
Reson Medical (China)
Innovative disposable stone extraction basket
Technology
MemoryPlus (Israel)
Combat memory loss and cognitive impairment by preventing synaptic failure
Technology
Hong Meng Medical (China)
Generic drugs on the synthesis process of esomeprazole magnesium
Technology
Novosonic（Israel）
“Nano-Beam” technology for cleaning and sterilization of medical Instruments
Technology
Ju Zheng Medical (China)
Artificial intelligence dental software
Technology
Jing Tai Bio (China)
Injectable peptide hydrogel for glaucoma filtering surgery
Technology
ZEK Technology (China)
Early children health management platform
Technology
Alagen Medical (China)
Unique drug carrying gel sticking technology and drug skin penetration technology
Technology
AXON (Israel)
An innovative attention-analysis engine (APE) based on artificial intelligence
Technology
CoreBone (Israel)
Bioactive coral bone graft for dental and orthopedic indications with unique technology
Technology
Richardson Bio-Tech (UK)
Developing China’s first third-party independent mycology diagnosis lab for diagnostic detection of invasive fungi
Technology
Application Process
Project Initiation
- Project introduction
- Preliminary discussion
Feasibility Study
- NDA
- Project materials
Internal Review
- Experts review
- Internal review
Business Consultation
- Term sheet
- Company preparation
Joint-Venture Establishment
- Business registration
- Investment capital
Special Fund Application
- Application materials
Application Review
- Expert review committee
Project Execution
- JV settled in BIG
- Received special fund support
Apply for incubation
Special Fund Policy
Policy link：http://eng.gdd.gov.cn/2023-09/20/c_923116.htm
Funding Amount
Read more
Incubation Period
2-5 years
Medical device projects:2-3 years incubation period
Biomedical projects:3-5 years incubation period
Projects are subject to milestone management during incubation.
Read more
Funding Usage
R&D expenditure
Special funds can be used for project R&D costs, managed and jointly supervised by the Guangzhou Development District's Development and Reform Department and BIG.
Read more
Funding Repayment
Repayment
When the conditions for repayment specified in the policy are met, the project company should repay the special funds obtained as required. The special funds do not generate any interest.
Read more
CONTACT US
Address：2/F Building 1, Unit 3, Guangzhou International Bio-Island, China
Call us: +8620 8911 7190
Email us: info@big-incubator.com
